Beclomethasone dipropionate

About Amneal Pharmaceuticals

Amneal Pharmaceuticals is a publicly traded, integrated biopharmaceutical company with a 20+ year history focused on expanding access to essential medicines. It operates across three core segments: Complex Generics, Biosciences (biosimilars and injectables), and Specialty branded pharmaceuticals, primarily in CNS and endocrine disorders. The company leverages over 1 million square feet of U.S. manufacturing capacity, has a robust pipeline with 69 pending ANDAs, and is led by its founding Patel brothers, aiming to bring manufacturing of critical medicines back to the United States.

Therapeutic Areas